http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106146371-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D293-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C391-02 |
| filingDate | 2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106146371-B |
| titleOfInvention | Benzisoelenazolone class compound metabolites, its synthetic method and its application |
| abstract | The present invention provides a kind of benzisoxa selenazoles derivative with general formula (I) or its pharmaceutically acceptable salt： Wherein：R 1 、R 2 It is identical or different, each stand alone as hydrogen, halogen (such as F, Cl), itrile group, nitro, C 1 ‑C 6 Alkyl, C 1 ‑C 6 Alkoxy, C 1 ‑C 6 Alkylthio group, N (C 1 ‑C 6 Alkyl) 2 、NH(C 1 ‑C 6 Alkyl), COOH, SO 3 H.The present invention also provides the Pharmaceutical composition comprising the compound and its application in antitumor drug is prepared. |
| priorityDate | 2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.